BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6192089)

  • 41. Cancer immunotherapy.
    Stewart TH
    Can Med Assoc J; 1980 Jan; 122(2):157. PubMed ID: 7363206
    [No Abstract]   [Full Text] [Related]  

  • 42. Adjuvant immunotherapy after surgery and radiotherapy for breast carcinoma.
    Papavasiliou C; Pappas J; Pavlatou M; Keramopoulos A; Giannakoulis N; Koumantakis E; Nicolaïdis C
    Strahlentherapie; 1982 Apr; 158(4):206-9. PubMed ID: 7101333
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunology of lung cancer.
    Holmes EC
    Chest; 1977 May; 71(5):643-4. PubMed ID: 852345
    [No Abstract]   [Full Text] [Related]  

  • 44. Non-small-cell lung cancer vaccine therapy: a concise review.
    O'Mahony D; Kummar S; Gutierrez ME
    J Clin Oncol; 2005 Dec; 23(35):9022-8. PubMed ID: 16219932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunotherapy in bronchial carcinoma].
    Havemann K
    Onkologie; 1980 Jun; 3(3):120-6. PubMed ID: 6258119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Our experience with nonspecific immunotherapy of tumour processes by BCG vaccine (author's transl)].
    Andrysek O; Mostecký H; Dienstbier Z
    Cas Lek Cesk; 1974 Sep; 113(38):1170-2. PubMed ID: 4607393
    [No Abstract]   [Full Text] [Related]  

  • 47. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
    Kakimi K; Nakajima J; Wada H
    Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [BCG and levamisole in the treatment of advanced forms of lung cancer].
    Szafrański W
    Pneumonol Pol; 1980 Nov; 48(11):779-82. PubMed ID: 7255219
    [No Abstract]   [Full Text] [Related]  

  • 49. Adverse reactions to intrapleural BCG.
    N Engl J Med; 1981 Jul; 305(3):167-8. PubMed ID: 6264294
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunotherapy of breast cancer (review of foreign literature)].
    Liapis MA
    Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
    [No Abstract]   [Full Text] [Related]  

  • 51. [Carcinoma of the breast. Immunobiology and immunotherapy].
    Sega E; Castelli M; Sega FM
    Minerva Ginecol; 1982 Nov; 34(11):981-4. PubMed ID: 7155428
    [No Abstract]   [Full Text] [Related]  

  • 52. Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1981 Nov; 82(5):649-57. PubMed ID: 7029149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine immunotherapy of non-small cell lung cancer.
    Dubinett SM; Kradin RL
    Reg Immunol; 1993; 5(3-4):232-43. PubMed ID: 8240940
    [No Abstract]   [Full Text] [Related]  

  • 54. Combination chemotherapy, radiotherapy, and BCG immunotherapy in extensive (metastatic) small cell carcinoma of the lung. A Southwest Oncology Group study.
    McCracken JD; Heilbrun L; White J; Reed R; Samson M; Saiers JH; Stephens R; Stuckey WJ; Bickers J; Livingston R
    Cancer; 1980 Dec; 46(11):2335-40. PubMed ID: 6254629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel approaches for the treatment of small cell lung cancer.
    Wakelee H; Kelly K
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):499-518. PubMed ID: 15094184
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunologic approaches to the management of ovarian carcinoma.
    Bast RC; Knapp RC
    Semin Oncol; 1984 Sep; 11(3):264-74. PubMed ID: 6207593
    [No Abstract]   [Full Text] [Related]  

  • 57. [Tumor immunologic aspects of lung cancer treatment].
    Nilsson B
    Lakartidningen; 1979 May; 76(20):1933-4. PubMed ID: 449470
    [No Abstract]   [Full Text] [Related]  

  • 58. Intralesional injection of BCG using the fibreoptic bronchoscope in the treatment of bronchogenic carcinoma.
    Millar JW; Hunter AM; Wightman AJ; Horne NW
    Eur J Respir Dis; 1980 Jun; 61(3):162-6. PubMed ID: 7439279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
    Giaccone G; Debruyne C; Felip E; Chapman PB; Grant SC; Millward M; Thiberville L; D'addario G; Coens C; Rome LS; Zatloukal P; Masso O; Legrand C
    J Clin Oncol; 2005 Oct; 23(28):6854-64. PubMed ID: 16192577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunotherapy of superficial bladder cancer.
    Shapiro A; Kadmon D; Catalona WJ; Ratliff TL
    J Urol; 1982 Nov; 128(5):891-4. PubMed ID: 6184490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.